Skip to main content

Table 1 Resolution IV fractional factorial screening design for determination of XIP and VAL by RP-HPLC

From: Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma

Std.

Run

Factor 1

Factor 2

Factor 3

Factor 4

Factor 5

Response 1

Response 2

A: pH

B: % MeOH

C: Flow rate (mL/min)

D: Detection wavelength (nm)

E: Buffer conc (Mm)

Resolution

Retention time (VAL) (min)

5

1

4

58

1.2

250

0.05

7.6

6.91

9

2

4

58

1

250

0.025

7.56

8

7

3

4

63

1.2

230

0.025

4.31

4.56

4

4

3

63

1.2

230

0.05

5.86

5.2

8

5

4

58

1

230

0.05

7.75

8.2

2

6

3

58

1

250

0.05

9.13

9.27

10

7

3

63

1

230

0.025

3.9

5.23

1

8

4

63

1

250

0.05

4.6

5.5

6

9

3

58

1.2

230

0.025

8.53

7.68

3

10

3

63

1.2

250

0.025

3.8

4.36